Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

No significant between-group differences were observed in the remaining biochemical parameters, including uric acid, creatinine, liver enzymes, lipid profile, vitamin D, PTH, and thyroid function (all p > 0.05).

Source: 3.2. Comparison of Biochemical Characteristics of the Study Population. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Clinical and Biochemical Features Associated with Coexisting Primary Aldosteronism in Patients with Obstructive Sleep Apnea: A Cross-Sectional Study

Source: Article title.

Consecutive patients aged 18 to 75 years who underwent overnight polysomnography because of clinical suspicion of obstructive sleep apnea were screened for eligibility.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Clinical and Biochemical Features Associated with Coexisting Primary Aldosteronism in Patients with Obstructive Sleep Apnea: A Cross-Sectional Study

Cross-sectional study · Diagnostics · 2026

Original publication title

Clinical and Biochemical Features Associated with Coexisting Primary Aldosteronism in Patients with Obstructive Sleep Apnea: A Cross-Sectional Study

Mingliu Li; Xuyong Chen; Yi Zhang; Yuanyuan Teng; Biling Huang; Min Tan; Zehao Liu; Min Guo; Chun Li; Xiaoli Su; Tiejian Jiang; Min Wang

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

Obstructive sleep apnea (OSA) and primary aldosteronism (PA) are linked by bidirectional mechanisms. Although guidelines recommend PA screening in hypertensive patients with OSA, simple tools for clinical prioritization remain limited. We aimed to characterize clinical, polysomnographic, and biochemical features associated with coexisting PA in patients with OSA.

Methods:

We conducted a cross-sectional study in 107 adults with OSA and definitive PA classification, including 30 patients in the OSA+PA group and 77 in the OSA-only group. Clinical, polysomnographic, and fasting biochemical variables were collected using standardized procedures. Multivariable logistic regression was used to examine factors associated with coexisting PA.

Results:

Compared with the OSA-only group, the OSA+PA group had a larger neck circumference (42.0 ± 4.6 vs. 39.8 ± 3.7 cm, p = 0.010), a higher snoring index (369.9 ± 320.3 vs. 252.0 ± 264.9, p = 0.040), and higher aldosterone levels (25.8 ± 18.8 vs. 10.7 ± 7.3 ng/dL, p = 0.001), while glycated hemoglobin was lower (6.4 ± 1.6 vs. 7.5 ± 2.1, p = 0.005) and serum potassium was significantly reduced (3.5 ± 0.4 vs. 4.0 ± 0.4 mmol/L, p = 0.001). In multivariable analysis, aldosterone (OR = 1.138, p = 0.001) and serum potassium (OR = 0.017, p = 0.001) were associated with coexisting PA.

Conclusions:

Higher aldosterone and lower serum potassium were readily available biochemical features associated with coexisting PA among clinically selected patients with OSA.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Obstructive sleep apnea (OSA) and primary aldosteronism (PA) are linked by bidirectional mechanisms. Although guidelines recommend PA screening in hypertensive patients with OSA, simple tools for clinical prioritization remain limited. We aimed to characterize clinical, polysomnographic, and biochemical features associated with coexisting PA in patients with OSA.

Source: Background:

Abstract: Results

Compared with the OSA-only group, the OSA+PA group had a larger neck circumference (42.0 ± 4.6 vs. 39.8 ± 3.7 cm, p = 0.010), a higher snoring index (369.9 ± 320.3 vs. 252.0 ± 264.9, p = 0.040), and higher aldosterone levels (25.8 ± 18.8 vs. 10.7 ± 7.3 ng/dL, p = 0.001), while glycated hemoglobin was lower (6.4 ± 1.6 vs. 7.5 ± 2.1, p = 0.005) and serum potassium was significantly reduced (3.5 ± 0.4 vs. 4.0 ± 0.4 mmol/L, p = 0.001). In multivariable analysis, aldosterone (OR = 1.138, p = 0.001) and serum potassium (OR = 0.017, p = 0.001) were associated with coexisting PA.

Source: Results:

Abstract: Conclusions

Higher aldosterone and lower serum potassium were readily available biochemical features associated with coexisting PA among clinically selected patients with OSA.

Source: Conclusions:
Authors’ abstract

Background:

Obstructive sleep apnea (OSA) and primary aldosteronism (PA) are linked by bidirectional mechanisms. Although guidelines recommend PA screening in hypertensive patients with OSA, simple tools for clinical prioritization remain limited. We aimed to characterize clinical, polysomnographic, and biochemical features associated with coexisting PA in patients with OSA.

Methods:

We conducted a cross-sectional study in 107 adults with OSA and definitive PA classification, including 30 patients in the OSA+PA group and 77 in the OSA-only group. Clinical, polysomnographic, and fasting biochemical variables were collected using standardized procedures. Multivariable logistic regression was used to examine factors associated with coexisting PA.

Results:

Compared with the OSA-only group, the OSA+PA group had a larger neck circumference (42.0 ± 4.6 vs. 39.8 ± 3.7 cm, p = 0.010), a higher snoring index (369.9 ± 320.3 vs. 252.0 ± 264.9, p = 0.040), and higher aldosterone levels (25.8 ± 18.8 vs. 10.7 ± 7.3 ng/dL, p = 0.001), while glycated hemoglobin was lower (6.4 ± 1.6 vs. 7.5 ± 2.1, p = 0.005) and serum potassium was significantly reduced (3.5 ± 0.4 vs. 4.0 ± 0.4 mmol/L, p = 0.001). In multivariable analysis, aldosterone (OR = 1.138, p = 0.001) and serum potassium (OR = 0.017, p = 0.001) were associated with coexisting PA.

Conclusions:

Higher aldosterone and lower serum potassium were readily available biochemical features associated with coexisting PA among clinically selected patients with OSA.

Publication and source details

Original title: Clinical and Biochemical Features Associated with Coexisting Primary Aldosteronism in Patients with Obstructive Sleep Apnea: A Cross-Sectional Study

Mingliu Li; Xuyong Chen; Yi Zhang; Yuanyuan Teng; Biling Huang; Min Tan; Zehao Liu; Min Guo; Chun Li; Xiaoli Su; Tiejian Jiang; Min Wang

Diagnostics · 2026

* Correspondence: minwang@csu.edu.cn
†

These authors contributed equally to this work.

© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.Sanming Project of Medicine in ShenzhenSZSM202411024 National Natural Science Foundation of Chinahttps://ror.org/01h0zpd94 8227093082571032Shenzhen High-level Hospital Construction Fund Peking University Shenzhen Hospital Scientific Research Fundhttps://ror.org/03kkjyb15 KYQD2026002 Clinical Research Fund of the National Clinical Research Center for Geriatric Disorders (Xiangya Hospital)https://ror.org/03ddkvp86 2023LNJJ9This study was supported by the Sanming Project of Medicine in Shenzhen (No. SZSM202411024), the National Natural Science Foundation of China (Nos. 82270930 and 82571032), the Shenzhen High-level Hospital Construction Fund and the Peking University Shenzhen Hospital Scientific Research Fund (No. KYQD2026002), and the Clinical Research Fund of the National Clinical Research Center for Geriatric Disorders (Xiangya Hospital) (No. 2023LNJJ9).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:54:41.200078+00:00

DOI: 10.3390/diagnostics16162565 · PMC13512833